文献速递心境障碍焦虑、强迫与应激相关障碍

Omega-3与多不饱和脂肪预防抑郁和焦虑症状:随机试验的系统综述与荟萃分析

Omega-3 and polyunsaturated fat for prevention of depression and anxiety symptoms: systematic review and meta-analysis of randomised trials.
PubMed 文献 · Br J Psychiatry · 2021-01-01

该系统综述与荟萃分析纳入31项随机试验,评估增加长链Omega-3、α-亚麻酸或总多不饱和脂肪对抑郁和焦虑症状的预防与治疗效果。结果显示,增加长链Omega-3对抑郁症状风险(RR 1.01, 95%CI 0.92-1.10)或焦虑症状(SMD 0.15, 95%CI 0.05-0.26)可能几乎没有影响,证据质量中等。对已存在抑郁的严重程度和缓解影响不明确,证据质量极低。

要点

  • 增加长链Omega-3对抑郁症状风险可能几乎没有影响(RR 1.01, 95%CI 0.92-1.10)。
  • 增加长链Omega-3对焦虑症状可能几乎没有影响(SMD 0.15, 95%CI 0.05-0.26)。
  • 对已存在抑郁的严重程度和缓解影响不明确,证据质量极低。

核心结论

  • 增加长链Omega-3补充剂对预防抑郁或焦虑症状可能几乎没有影响。

研究设计与样本

  • 系统综述与荟萃分析,检索Central、Medline和EMBASE至2017年4月,试验注册库至2016年9月,进行中试验更新至2019年8月。
  • 纳入成人随机试验,干预为增加Omega-3、Omega-6或总多不饱和脂肪至少24周,排除多因素干预。

主要发现

  • 增加长链Omega-3对抑郁症状风险可能几乎没有影响(风险比1.01, 95%CI 0.92-1.10, I2=0%,中位剂量0.95 g/d,持续时间12个月),证据质量中等。
  • 增加长链Omega-3对焦虑症状可能几乎没有影响(标准化均数差0.15, 95%CI 0.05-0.26, I2=0%,中位剂量1.1 g/d,持续时间6个月),证据质量中等。
  • 对已存在抑郁的抑郁严重程度和缓解的影响证据不明确,证据质量极低。
  • 增加α-亚麻酸2 g/d可能在40个月内非常轻微地增加抑郁症状风险(需伤害人数1000)。

关键数值与推荐

  • 长链Omega-3对抑郁症状风险:风险比1.01(95%CI 0.92-1.10),中位剂量0.95 g/d,持续时间12个月。
  • 长链Omega-3对焦虑症状:标准化均数差0.15(95%CI 0.05-0.26),中位剂量1.1 g/d,持续时间6个月。
  • α-亚麻酸2 g/d增加抑郁症状风险需伤害人数1000(40个月)。

临床怎么用

  • 基于中等质量证据,长链Omega-3补充剂不推荐用于预防抑郁或焦虑症状。
  • 对已存在抑郁的患者,Omega-3对严重程度和缓解的影响不明确,临床决策需谨慎。

局限性

  • 对已存在抑郁的严重程度和缓解证据质量极低。
  • 无Omega-6试验,总多不饱和脂肪和α-亚麻酸试验数量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is strong public belief that polyunsaturated fats protect against and ameliorate depression and anxiety. AIMS: To assess effects of increasing omega-3, omega-6 or total polyunsaturated fat on prevention and treatment of depression and anxiety symptoms. METHOD: We searched widely (Central, Medline and EMBASE to April 2017, trial registers to September 2016, ongoing trials updated to August 2019), including trials of adults with or without depression or anxiety, randomised to increased omega-3, omega-6 or total polyunsaturated fat for ≥24 weeks, excluding multifactorial interventions. Inclusion, data extraction and risk of bias were assessed independently in duplicate, and authors contacted for further data. We used random-effects meta-analysis, sensitivity analyses, subgrouping and Grading of Recommendations, Assessment, Development and Evaluations (GRADE) assessment. RESULTS: We included 31 trials assessing effects of long-chain omega-3 (n = 41 470), one of alpha-linolenic acid (n = 4837), one of total polyunsaturated fat (n = 4997) and none of omega-6. Meta-analysis suggested that increasing long-chain omega-3 probably has little or no effect on risk of depression symptoms (risk ratio 1.01, 95% CI 0.92-1.10, I2 = 0%, median dose 0.95 g/d, duration 12 months) or anxiety symptoms (standardised mean difference 0.15, 95% CI 0.05-0.26, I2 = 0%, median dose 1.1 g/d, duration 6 months; both moderate-quality evidence). Evidence of effects on depression severity and remission in existing depression were unclear (very-low-quality evidence). Results did not differ by risk of bias, omega-3 dose, duration or nutrients replaced. Increasing alpha-linolenic acid by 2 g/d may increase risk of depression symptoms very slightly over 40 months (number needed to harm, 1000). CONCLUSIONS: Long-chain omega-3 supplementation probably has little or no effect in preventing depression or anxiety symptoms. DECLARATION OF INTEREST: L.H. and A.A. were funded to attend the World Health Organization Nutrition Guidance Expert Advisory Group (NUGAG) Subgroup on Diet and Health meetings and present review results. The authors report no other conflicts of interest.

来源:Br J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Deane KHO, Jimoh OF, Biswas P, et al. Omega-3 and polyunsaturated fat for prevention of depression and anxiety symptoms: systematic review and meta-analysis of randomised trials. Br J Psychiatry. 2021. PMID: 31647041. doi:10.1192/bjp.2019.234

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。